Target intelligence / Profile preview

Blood glucose regulation via slowed carbohydrate absorption

Molecular classification
Enzyme (e.g., α-glucosidase), Transporter (e.g., SGLT1), Other (digestive processes)
01

Overview

"Blood glucose regulation via slowed carbohydrate absorption" refers to strategies—both dietary and pharmacologic—that aim to reduce the rate at which ingested carbohydrates are digested and absorbed from the gut into circulation. By inhibiting key digestive enzymes such as α-glucosidase at the small intestine's brush border, these approaches slow down conversion of complex carbs into absorbable sugars like glucose. This results in blunted spikes in post-meal blood sugar—a benefit particularly relevant for people with type 2 diabetes or impaired glycemic control. Alpha-glucosidase inhibitors exemplify this approach pharmacologically; dietary fiber-rich foods achieve similar effects naturally through delayed gastric emptying and altered substrate availability for enzymatic breakdown. This entry does not correspond to any one molecule or receptor but encompasses several targets within digestive physiology—primarily gut enzymes involved in starch/sugar hydrolysis—and should be reclassified accordingly if structured data on individual molecules is required.

Other names
Slowed carbohydrate absorptionDelayed carbohydrate digestionReduced postprandial glucose rise
02

Mechanism of action

Inhibition of intestinal disaccharidases/α-glucosidases at the brush border slows conversion of oligosaccharides/disaccharides to monosaccharides, delaying their uptake into circulation, resulting in reduced peak postprandial blood sugar levels.

03

Biological functions

Carbohydrate digestionGlucose absorptionRegulation of postprandial blood glucose
04

Disease associations

Type 2 diabetes mellitusMetabolic syndrome
05

Safety considerations

Gastrointestinal side effects are common (flatulence, diarrhea, abdominal discomfort) due to undigested carbohydrates reaching the colon where they are fermented by bacteria.Potential risk with excessive slowing of carbohydrate absorption includes hypoglycemia if combined with other antidiabetic agents.
06

Interacting drugs

acarbose

2 more in the full profile.

07

Biomarkers

Postprandial plasma glucose measurementsHemoglobin A1C

Beyond the preview

Go deeper on Blood glucose regulation via slowed carbohydrate absorption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood glucose regulation via slowed carbohydrate absorption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call